• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Report: Nevada’s Heller pushed unapproved TMS treatment on VA

Report: Nevada’s Heller pushed unapproved TMS treatment on VA

October 18, 2018 By Fink Densford

Nevada Senator Dean Heller (R-NV) encouraged doctors at a Reno-based Veterans Affairs medical center to use an off-label transcranial magnetic stimulation technology marketed by a company with connections to his office, according to a new ProPublica report.

The company, called CereCare, markets a technology it says uses electrical scans of the brain and heart to detect an “intrinsic brainwave frequency” to identify areas of the brain “in need of restoration,” according the the report. The areas are then targeted with stimulation from a TMS system.

The meeting was arranged because two partners at CereCare had a connection to a senior aide to Heller in Reno, according to ProPublica. Heller went on to co-sponsor a bill looking to start a pilot program on CereCare’s procedure.

CereCare partner Jodi Kosterman, who labels themselves as “Dr.” on their business cards despite having no medical degree, reportedly joined in drafting the bill, describing themselves as an expert on the procedure.

In consideration of the procedure being off-label, CereCare partner Nino Pedrini suggested that “the thing we all have to get over is FDA approval on some things,” according to ProPublica.

“You’ve got to try things. We can’t get hung up on 20 years of the FDA trying to approve something because of the bureaucracy and red tape,” Pedrini said, according to the report.

The pilot, and other such attempts to use experimental and off-label procedures with the VA have met with push back from mental health professionals, who strongly support the use of treatments that are scientifically validated, according to ProPublica.

The pilot program never moved forward, due to issues with clearances, approvals and reviews, according to the report.

Filed Under: Business/Financial News, Featured, Neurological Tagged With: cerecare

More recent news

  • Aurora Spine begins first procedures with Aero lumbar fusion system
  • Caranx Medical surgical robot TaviPilot AI software wins FDA clearance
  • InspireMD launches carotid stent in U.S. after FDA approval
  • Neuros Medical raises $56M Series D to support nerve stim tech
  • CorWave reports first-in-human LVAD implant

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy